Jefferies issues bullish note on buy-rated OrganiGram, upgrades Cronos and Hexo and cuts Tilray’s price target

Jefferies upgraded two Canadian cannabis stocks on Thursday and reduced his price target on a third, while remaining most bullish on buy-rated OrganiGram Holdings Inc., which it said is “really starti...

Tilray expected to grow sales sequentially but remain in the red

Tilray Inc. will likely grow its sales over the previous quarter but it’s expected to post a net loss when it becomes the first major cannabis company to post quarterly results in 2022 on Monday. Tilr...